作者: Peter C. Fuchs , Arthur L. Barry , Steven D. Brown
关键词: Antimicrobial 、 Sepsis 、 Dextran 70 、 Polymyxin B 、 Microbiology 、 In vitro 、 Antibiotics 、 Biology
摘要: Because of its capacity to neutralize the lethality gram-negative bacterial endotoxic lipopolysaccharides, PMX-622 (polymyxin B bound dextran 70) is being developed for possible adjunctive therapy sepsis. In this study, it was determined that in vitro antimicrobial activity minimal and does not interfere with 11 antibiotics commonly used treat infections.